Metropolitan Life Insurance Company (MetLife)’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,808
| Closed | -$12.2K | – | 50 |
|
|
2024
Q1 | $12.2K | Sell |
3,808
-3,415
| -47% | -$11K | ﹤0.01% | 2060 |
|
|
2023
Q4 | $35.4K | Hold |
7,223
| – | – | ﹤0.01% | 1625 |
|
|
2023
Q3 | $39.4K | Buy |
7,223
+1,098
| +18% | +$5.98K | ﹤0.01% | 1537 |
|
|
2023
Q2 | $41.1K | Buy |
6,125
+819
| +15% | +$5.5K | ﹤0.01% | 1540 |
|
|
2023
Q1 | $46.9K | Sell |
5,306
-1,456
| -22% | -$12.9K | ﹤0.01% | 1424 |
|
|
2022
Q4 | $51.7K | Hold |
6,762
| – | – | ﹤0.01% | 1452 |
|
|
2022
Q3 | $48.1K | Hold |
6,762
| – | – | ﹤0.01% | 1481 |
|
|
2022
Q2 | $54.7K | Buy |
+6,762
| New | +$54.7K | ﹤0.01% | 1445 |
|
|
2022
Q1 | – | Sell |
-6,686
| Closed | -$188K | – | 2249 |
|
|
2021
Q4 | $188K | Sell |
6,686
-49
| -0.7% | -$1.38K | ﹤0.01% | 2073 |
|
|
2021
Q3 | $229K | Sell |
6,735
-224
| -3% | -$7.61K | ﹤0.01% | 1970 |
|
|
2021
Q2 | $284K | Buy |
6,959
+1,419
| +26% | +$58K | ﹤0.01% | 1897 |
|
|
2021
Q1 | $223K | Sell |
5,540
-249
| -4% | -$10K | ﹤0.01% | 1941 |
|
|
2020
Q4 | $342K | Sell |
5,789
-113
| -2% | -$6.68K | 0.01% | 1608 |
|
|
2020
Q3 | $287K | Buy |
5,902
+252
| +4% | +$12.3K | ﹤0.01% | 1569 |
|
|
2020
Q2 | $273K | Buy |
5,650
+1,861
| +49% | +$90K | ﹤0.01% | 1607 |
|
|
2020
Q1 | $105K | Buy |
3,789
+2,830
| +295% | +$78.6K | ﹤0.01% | 2000 |
|
|
2019
Q4 | $28.7K | Sell |
959
-15
| -2% | -$449 | ﹤0.01% | 2513 |
|
|
2019
Q3 | $30.1K | Buy |
+974
| New | +$30.1K | ﹤0.01% | 2533 |
|